Byun So Young, Kim Hee Sung, Ahn Ji Yong, Kim Byung Sik, Na Hee Kyong, Lee Jeong Hoon, Jung Kee Wook, Kim Do Hoon, Choi Kee Don, Song Ho June, Lee Gin Hyug, Jung Hwoon-Yong
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Gastric Surgery, Gangnam CHA Medical Center, Seoul, Korea.
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):268-275. doi: 10.7704/kjhugr.2025.0029. Epub 2025 Sep 1.
Helicobacter pylori eradication treatment typically occurs after gastrectomy; however, the specific criteria for eradication treatment have not been reported. This study aimed to evaluate the rates and locations of spontaneous clearance, as well as the accompanying histological changes.
Patients with H. pylori-positive status at the time of gastric cancer diagnosis and who underwent subtotal gastrectomy at a tertiary care center in Seoul (South Korea) were prospectively enrolled in this study. H. pylori infection status and histological features (presence of mononuclear cells, neutrophils, atrophy, and intestinal metaplasia) were evaluated pre- and postoperatively at different locations in the stomach.
Sixteen patients with H. pylori-positive gastric cancer underwent subtotal gastrectomy. Of these, 13 (81.3%) showed spontaneous clearance at least once during the follow-up. Half of the patients (8, 50.0%) had cleared their infections within 6 months after surgery. Histological factors, such as neutrophil and mononuclear cell counts, atrophy, and intestinal metaplasia, did not differ according to H. pylori clearance status. The spontaneous clearance rates of H. pylori were 69.2% in the cardia, 46.1% in the fundus, 38.4% in the lesser curvature of the mid-body, and 41.6% in the greater curvature of the mid-body; the differences in clearance rates were not significant (p=0.149).
The rate of spontaneous H. pylori clearance was high in patients with gastric cancer who underwent subtotal gastrectomy. Postoperative H. pylori status should be re-evaluated to confirm the presence of infection prior to considering eradicating therapy.
幽门螺杆菌根除治疗通常在胃切除术后进行;然而,根除治疗的具体标准尚未见报道。本研究旨在评估自发清除率、清除部位以及伴随的组织学变化。
前瞻性纳入在韩国首尔一家三级医疗中心诊断为胃癌时幽门螺杆菌阳性且接受了胃大部切除术的患者。在胃的不同部位术前和术后评估幽门螺杆菌感染状况和组织学特征(单核细胞、中性粒细胞、萎缩和肠化生的存在情况)。
16例幽门螺杆菌阳性的胃癌患者接受了胃大部切除术。其中,13例(81.3%)在随访期间至少有一次自发清除。半数患者(8例,50.0%)在术后6个月内清除了感染。组织学因素,如中性粒细胞和单核细胞计数、萎缩和肠化生,根据幽门螺杆菌清除状态并无差异。幽门螺杆菌的自发清除率在贲门部为69.2%,胃底部为46.1%,胃体小弯侧为38.4%,胃体大弯侧为41.6%;清除率差异无统计学意义(p = 0.149)。
接受胃大部切除术的胃癌患者中幽门螺杆菌自发清除率较高。在考虑根除治疗之前,应重新评估术后幽门螺杆菌状态以确认感染是否存在。